Trials / Completed
CompletedNCT02100345
Conservative Treatment of Rectosigmoid Endometriosis Monitored by Transvaginal Ultrasound
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 98 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- Female
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Background: Endometriosis is a disease affecting 8-15 % of fertile women and is a cause of abdominal pain and suffering during women's menstrual periods. A subgroup of patients with DIE has an infiltration into the rectosigmoid bowel wall (4-37%). Knowledge of the growth pattern of rectosigmoid lesions related to subjective symptoms is mandatory in order to assess the need for follow-up with transvaginal ultrasound during medical treatment. Hypotheses: Symptoms will follow growth of rectosigmoid endometriosis. Material and methods: Two different cohorts of women, based on time of diagnosis of rectosigmoid endometriosis and treatment with hormonal intrauterine device or continuous oral contraceptives will receive a questionnaire and a transvaginal ultrasound scan (measuring size and volume) at inclusion, (6) and 12 months later. Perspectives: Patients treated conservatively may be followed by questionnaires, thereby reducing the need for time consuming clinical controls.
Conditions
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2014-03-31
- Last updated
- 2017-05-09
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02100345. Inclusion in this directory is not an endorsement.